Pancreatic cancer isn’t just a science problem.
It’s a capital problem.
Of the 1,000+ early-stage cancer companies in our pipeline, more than 200 are diagnostic, therapeutic, and other innovations relevant to pancreatic cancer. For most of these companies, the critical problem isn’t science. It’s capital.
Where Are We Now?
We’re evaluating the innovations of 200+ early-stage companies with the potential to help impact pancreatic cancer.
TWO PATHS, ONE MISSION
That’s Where You Come In. Will You Join Us?
Two Ways to Participate
Choose the path that BEST fits your goals.
FOR CHARITABLE SUPPORTERS:
The CANCER FUND Community Donor-Advised Fund (CFC-DAF) at ImpactAssets is open to everyone — accredited or not.
FOR INVESTORS
Cancer Fund I, LLC is an early-stage venture fund offered under Rule 506(c) of Regulation D, open to verified accredited investors only; see subscription documents for current minimum and terms.
CANCER FUND is something different.
It’s a community built on a simple insight that many patients, survivors, and the people who care for them and about them already know but nobody had acted on.
GET INVOLVED
Your perspective matters here.
You don’t need a medical degree or an investment background. Patients, survivors, caregivers, scientists, physicians, and investors all have a seat at the table.
We don’t sit in a boardroom and pick the innovations we support. Our Screening Committee helps review what we’re considering. Initial reviews only take 2-3 minutes. But, as we progress through our evaluation process and our review teams get smaller, our evaluations get progressively more detailed, and take longer.
If you’re interested in being part of it, learn more here.